homocysteine has been researched along with Disease Exacerbation in 170 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (3.53) | 18.2507 |
2000's | 78 (45.88) | 29.6817 |
2010's | 76 (44.71) | 24.3611 |
2020's | 10 (5.88) | 2.80 |
Authors | Studies |
---|---|
Christine, CW; Green, R | 1 |
Futschek, IE; Haslacher, H; Lehrner, J; Schernhammer, E; Stögmann, E | 1 |
Ghorbani, Z; Martami, F; Razeghi Jahromi, S; Seifishahpar, M; Togha, M | 1 |
Chen, X; Chen, Y; Chen, Z; Fan, R; Jiang, Y; Liang, J; Liu, J; Peng, F; Tong, J | 1 |
Deng, M; Guo, W; Jiang, Y; Ma, P; Ma, S; Mao, C; Nie, L; Sun, J; Sun, L; Wang, N; Xiong, J; Yang, A; Zhang, H | 1 |
Budoff, MJ; Garg, PK; Guan, W; Karger, AB; Nomura, SO; Steffen, BT; Szklo, M; Tsai, MY | 1 |
Han, J; Hu, W; Li, X; Yuan, J | 1 |
Chen, J; Cui, T; Gao, T; Jian, Z; Li, C; Li, K; Li, S; Liu, L; Ni, Q; Song, P; Tian, Y; Yi, X; Zhang, W; Zhuang, T | 1 |
Bosevski, M; Gjorgievski, A; Lazarova, E; Petkoska, D; Stojanovska, L; Zlatanovikj, N | 1 |
Li, C; Liu, Y; Tian, T; Wei, B | 1 |
Chen, G; Fan, X; Jin, Y; Li, H; Ma, X; Qi, G; Zhang, L | 1 |
Bai, Y; Cao, R; Wang, F; Wang, X; Xiao, W; Ye, P | 1 |
Kang, MJ; Lee, H; Lee, YB; Park, HM; Park, KH; Shin, DH; Shin, DJ; Sung, YH; Yang, JW | 1 |
Farina, N; Hart, K; Jernerén, F; Tabet, N; Turner, C | 1 |
Dong, Y; Liu, H; Luo, C; Sun, Q; Wang, H; Wang, W; Wu, Y; Xu, J; Zhang, H; Zhou, Y | 1 |
Cui, BB; Fu, RL; Geng, HH; Jin, YP; Li, B; Wang, JJ; Wang, PX; Wang, Q; Zhang, Q | 1 |
Bosi, C; Brombo, G; Cervellati, C; Morieri, ML; Passaro, A; Trentini, A; Valacchi, G; Zuliani, G; Zurlo, A | 1 |
Li, L; Liu, J; Wang, H; Zhao, H; Zhao, XX; Zhou, Y | 1 |
Cui, C; Fernandez-Escobar, A; Jin, M; Liu, Z; Mao, J; Wang, K; Wang, X; Wu, Q; Xu, K | 1 |
Apeland, T; Jonsson, G; Mansoor, MA; Marti, HP; Slettan, A; Tariq, A; Weeraman, P | 1 |
Chen, J; Cui, X; Ding, X; Fang, Y; Kuang, Q; Shen, Z; Xue, N | 1 |
Alfieri, DF; de Almeida, ERD; Dichi, I; Flauzino, T; Kaimen-Maciel, DR; Kallaur, AP; Lozovoy, MAB; Morimoto, HK; Oliveira, SR; Reiche, EMV; Sabino, BS; Simão, ANC | 1 |
Brodacki, B; Piusińska-Macoch, R; Skrobowska, E; Staszewski, J; Stępień, A | 1 |
Bhadelia, RA; Folstein, MF; Qiu, WQ; Rosenberg, IH; Scott, TM | 1 |
Alarcón, GS; Alfaro-Lozano, JL; Cucho-Venegas, JM; Elera-Fitzcarrald, C; Gamboa-Cárdenas, RV; Iparraguirre-López, H; Medina-Chinchon, M; Pastor-Asurza, CA; Perich-Campos, RA; Pimentel-Quiroz, VR; Reátegui-Sokolova, C; Rodríguez-Bellido, ZJ; Sarmiento-Velasquez, O; Ugarte-Gil, MF; Zeña-Huancas, PA; Zevallos-Miranda, F | 1 |
Allan, AM; Brigman, J; Jacobsen, DW; Jindal, A; Miller, JW; Paul, S; Poddar, R; Rajagopal, S; Winter, L | 1 |
Burn, DJ; Duncan, GW; Johnston, F; Khoo, TK; Lawson, RA; Sleeman, I; Yarnall, AJ | 1 |
Aksamit, D; Drozdz, M; Ignacak, E; Janda, K; Kowalczyk-Michałek, M; Krzanowski, M; Sułowicz, W; Tabor-Ciepiela, B | 1 |
Ahmadi, N; Budoff, M; Ebrahimi, R; Flores, F; Hajsadeghi, F; Nabavi, V; Zeb, I | 1 |
Bertini, E; Boenzi, S; Di Giovamberardino, G; Dionisi-Vici, C; Martinelli, D; Pastore, A; Petrillo, S; Piemonte, F; Tozzi, G | 1 |
Chang, AY; Chang, CC; Chang, WN; Chang, YT; Chen, NC; Huang, CW; Huang, SH; Lee, CC; Lui, CC | 1 |
Ahluwalia, N; Blacher, J; Faure, P; Galan, P; Hercberg, S; Julia, C; Szabo de Edelenyi, F | 1 |
Bulum, T; Duvnjak, L | 1 |
Han, SJ; Jang, HS; Jung, KJ; Kim, JI; Park, JW; Park, KM | 1 |
Andras, A; Hansrani, M; Stansby, G | 1 |
Digumarti, RR; Divyya, S; Gottumukkala, SR; Kotamraju, S; Kumaraswami, K; Kutala, VK; Naushad, SM; Reddy, CA | 1 |
Li, H; Li, J; Lu, Z; Men, X; Zhang, B; Zhang, L | 1 |
Charles-Schoeman, C; Fitzgerald, J; Gorn, A; Grossman, JM; Hahn, BH; Karpouzas, GA; Lourenco, EV; McMahon, M; Ragavendra, N; Sahakian, L; Skaggs, BJ; Taylor, MB; Wallace, DJ; Watson, KE; Weisman, MH; Wong, WK | 1 |
Geerlings, MI; Kloppenborg, RP; Mali, WP; Nederkoorn, PJ; van der Graaf, Y; Vermeulen, M; Visseren, FL | 1 |
Li, J; Shi, M; Xie, M; Yan, L; Zhang, H | 1 |
Basu, A; Garvey, WT; Jenkins, AJ; Klein, RL; Lopes-Virella, MF; Lyons, TJ; Stoner, JA; Thorpe, SR | 1 |
Callà, C; De Stefano, A; Dessì, M; Di Daniele, N; Di Giovamberardino, G; Noce, A; Pastore, A; Zenobi, R | 1 |
Cohen, E; Garty, M; Goldberg, E; Krause, I; Levi, A; Levi, M | 1 |
Aliani, M; House, JD; Mayengbam, S; Raposo, S | 1 |
Hlushchenko, SV; Zviagintseva, TD | 1 |
Catena, C; Colussi, G; Nait, F; Sechi, LA; Url-Michitsch, M | 1 |
Fernández Castillo, R; Fernández Gallegos, R; Gomez Jimenez, FJ; Quero Alfonso, AI | 1 |
Asghari, A; Eidi, A; Mohammadian, Z; Mortazavi, P; Tavangar, MM | 1 |
Bang, H; Spence, JD; Urquhart, BL | 1 |
Ge, SJ; Guan, ZH; Hu, MY; Zhang, HL; Zhang, T; Zheng, LQ | 1 |
Ansari, Z | 1 |
Duan, S; Li, L; Ren, C; Xie, J; Zhang, S | 1 |
Cui, Y; Kong, X; Wei, W; Wei, Y; Zhang, J; Zheng, L | 1 |
Fendler, W; Lukamowicz, J; Miklaszewska, M; Tkaczyk, M | 1 |
Amin, HK; El-Sayed, MI; Leheta, OF | 1 |
Hou, FF; Huo, Y; Li, Y; Liang, M; Qin, X; Sun, D; Wang, B; Wang, J; Xu, X | 1 |
Bickel, C; Blankenberg, S; Lackner, K; Lubos, E; Proust, C; Rupprecht, H; Schnabel, RB; Sinning, C; Tregouet, D; Westermann, D; Zengin, E | 1 |
Bala, J; Behera, J; Nuru, M; Tyagi, N; Tyagi, SC | 1 |
Oláh, E; V Oláh, A; Varga, P | 1 |
Loftus, I; Thompson, M | 1 |
Blom, HJ; Dijkstra, CD; Killestein, J; Kragt, JJ; Polman, CH; Teunissen, CE | 1 |
Kristofova, B; Valocik, G; Valocikova, I | 1 |
Dagenais, G; Held, C; Lonn, E; McQueen, M; Sheridan, P; Smith, S; Sumner, G; Yusuf, S | 1 |
Aliabadi, P; Fayfman, M; Felson, DT; Hunter, DJ; Niu, J; Sack, B; Selhub, J; Zhang, YQ | 1 |
Alaupovic, P; Azen, SP; Detrano, R; Dustin, L; Hodis, HN; Hwang, J; Liu, CH; Liu, CR; Mack, WJ; Mahrer, PR; Selhub, J; Selzer, RH; Wilcox, AG | 1 |
Ochudło, S; Opala, G; Siuda, J; Targosz-Gajniak, M | 1 |
Aksungar, FB; Bektaş, O; Levent, E; Sariman, N; Soylu, AC | 1 |
Akgül, E; Kaya, C; Pabuccu, R | 1 |
Avilés, F; Burgos, MI; Fenollar, M; Parra, MS | 1 |
Croxford, R; Depeint, F; Kim, YI; Lindzon, GM; Medline, A; Sohn, KJ | 1 |
Annerbo, S; Kivipelto, M; Lokk, J | 1 |
Boehm, BO; Fuchs, D; Grammer, TB; März, W; Schroecksnadel, K | 1 |
Amato, A; Cini, M; Conti, E; Favaretto, E; Legnani, C; Palareti, G; Sartori, M | 1 |
Chung, WS; Ihm, SH; Kim, DB; Kim, HY; Kim, JH; Lee, JM; Park, CS; Seung, KB; Yoo, KD | 1 |
Handels, R; van Rossum, IA; Visser, PJ; Vos, S | 1 |
Bleie, O; Blix, AJ; Ebbing, M; Løland, KH; Nordrehaug, JE; Nygård, O; Refsum, H; Strand, E; Ueland, PM | 1 |
Ansquer, JC; Brugère, L; Foucher, C | 1 |
Albanese, A; Bowlus, CL; Devaraj, S; French, SW; Gregory, JF; Halsted, CH; Medici, V; Panacek, EA; Peerson, JM; Rahim, N; Richards, JR; Rossaro, L; Stabler, SP; Virata, MC | 1 |
Rabbani, N; Thornalley, PJ | 1 |
Collin, SM; Cox, A; Davis, M; Donovan, JL; Hamdy, FC; Johnston, C; Lane, JA; Lewis, SJ; Marsden, G; Martin, RM; Metcalfe, C; Neal, DE; Refsum, H; Smith, AD; Smith, GD | 1 |
Bathgate, D; Chinnery, PF; Fowler, B; Taylor, RW; Webb, B; Yu-Wai-Man, P | 1 |
Bots, ML; Durga, J; Grobbee, DE; Kok, FJ; Schouten, EG; Verhoef, P | 1 |
Liu, WH; Liu, WJ; Ma, LQ; Zhang, KQ; Zhou, W; Zou, CG | 1 |
Müller, T | 1 |
Firbank, MJ; Ford, GA; Hansrani, M; Narayan, SK; O'Brien, JT; Saxby, BK; Stansby, G | 1 |
Hirayama, A; Nagao, K; Nomoto, K; Tani, S; Washio, T; Watanabe, I | 1 |
Ambrožič, A; Cikeš, N; Cučnik, S; Hojs, R; Holc, I; Kveder, T; Pahor, A; Rozman, B | 1 |
Chai, HT; Chang, LT; Chen, HC; Chen, YL; Chung, SY; Fan, CQ; Sun, CK; Sung, PH; Tsai, TH; Yang, CH; Yip, HK | 1 |
Gao, C; Gao, Y; Li, X; Wei, S; Zhang, M; Zhong, L | 1 |
Carducci, MA; Herman, JG; Shabbeer, S; Simons, BW; Williams, SA | 1 |
Huo, Y; Li, J; Qin, X; Wang, X; Xu, M; Xu, X; Zhang, Y | 1 |
Durajski, L; Fijorek, K; Głowacki, R; Kozynacka, A; Mazur, P; Pfitzner, R; Sadowski, J; Undas, A | 1 |
Demidova, VS; Doguzhieva, RM; Lebedeva, AN; Pokrovskiĭ, AV | 1 |
Chłopicki, S; Franczyk-Żarów, M; Gajda, M; Jackson, CL; Kostogrys, RB; Maślak, E; Mateuszuk, L | 1 |
de Groot, LC; Geerlings, MI; Jochemsen, HM; Kampman, E; Kloppenborg, RP; Mali, WP; van der Graaf, Y | 1 |
Ascaso, JF; Chaves, FJ; Folgado, J; Gonzalez, R; Lorente, R; Martínez-Hervás, S; Molina, M; Priego, A; Real, JT | 1 |
Hansrani, M; Stansby, G | 1 |
Grzeszczak, W; Gumprecht, J; Zukowska-Szczechowska, E; Zychma, MJ | 1 |
Ambrose, JA; Bilianou, HI; DeVoe, MC; Fakiolas, CN; Foussas, SG; Manousakis, SJ; Olympios, CD; Papadaki, OA; Pissimissis, EG; Stefanidis, AS; Zairis, MN | 1 |
Beck, GJ; Greene, T; Kusek, JW; Levey, AS; Sarnak, MJ; Selhub, J; Wang, SR | 1 |
Frick, B; Fuchs, D; Schröcksnadel, K | 1 |
Bleich, S; Falkai, P; Kessler, H; Supprian, T | 1 |
Chmiel, G; Drozdz, M; Klimeczek, P; Konieczyńska, M; Kowalczyk-Michałek, M; Kraśniak, A; Pasowicz, M; Podolec, P; Sułowicz, W; Szumilak, D; Tracz, W; Wicher-Muniak, E | 1 |
Griffin, BP; Novaro, GM | 1 |
Chodakowska-Zebrowska, M; Pniewski, J; Stafiej, A; Stepień, K; Woźniak, R | 1 |
Taylor, LM | 1 |
Aranda, JL; Díaz-Rubio, P; Fernández-Miranda, C; Gómez de la Cámara, A; Gómez, P; Martínez, J; Núñez, V; Paz, M | 1 |
Agelink, MW; Andrich, J; Arz, A; Kraus, PH; Kuhn, W; Müller, T; Saft, C; Schneider, B | 1 |
Frick, MH; Humphries, SE; Kesäniemi, YA; Nieminen, MS; Pasternack, A; Syvänne, M; Taskinen, MR; Turpeinen, U; Whittall, RA | 1 |
Arai, H; Maruyama, M; Matsui, T; Nemoto, M; Ootsuki, M; Sasaki, H; Tanji, H; Tomita, N | 1 |
Kowalska, I; Lewczuk, A; Mroczko, B; Musiał, W; Prokop, J; Sawicki, R; Skibińska, E | 1 |
Alberola, V; Almenar, D; Artal, A; Barcelo, R; Bover, I; Camps, C; Cobo, M; de las Peñas, R; Diz, P; Garcia-Gomez, R; Gonzalez-Larria, JL; Insa, A; Isla, D; Massuti, B; Muñoz, MA; Rosell, R; Sanchez, JJ; Sanchez-Ronco, M; Sarries, C; Taron, M; Terrasa, J | 1 |
Gustafson, L; Hultberg, B; Nilsson, K | 1 |
Davies, G; Duguid, J; Gray, R; Hill, D; Hudson, P; McCaddon, A; Tandy, S | 1 |
Lang, AE; Postuma, RB | 1 |
Harringer, W; Haverich, A; Kutschka, I; Pethig, K; Strüber, M | 1 |
Aggarwal, SP; Narang, AP; Sandhu, JS; Sandhu, P; Singh, I | 1 |
Giusti, B; Lapini, I; Lenti, M; Marcucci, R; Pepe, G; Sestini, I; Yacoub, M | 1 |
Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR | 1 |
Boxer, AL; Finley, R; Goldman, J; Johnston, K; Kramer, JH; Miller, BL | 1 |
Allen, RH; Brown, TR; DeCarli, C; Paik, MC; Sacco, RL; Stabler, SP; Wright, CB | 1 |
Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
Bukia, T; Chaava, M; Gogokhia, N | 1 |
Aziz, DC; Blumenthal, RS; Budoff, MJ; Nasir, K; Park, R; Rasouli, ML | 1 |
Naidoo, D; Salonikas, C; Sim, AS; Wang, J; Wang, XL; Wilcken, DE | 1 |
Malberti, F; Mallamaci, F; Ravani, P; Testa, S; Tripepi, G; Zoccali, C | 1 |
Fowler, B | 1 |
Branzi, A; Carigi, S; Coccolo, F; Grigioni, F; Kessels, K; Koessels, K; Magelli, C; Magnani, G; Marrozzini, C; Marzocchi, A; Musuraca, AC; Ortolani, P; Potena, L; Russo, A; Sassi, S | 1 |
Zoccali, C | 1 |
Hu, R; Lau, CP; Tse, HF; Wang, WQ; Zhang, XX | 1 |
Bartis, C; Bottiglieri, T; Dewey, RB; Diaz-Arrastia, R; O'Suilleabhain, PE; Oberle, R | 1 |
Belaia, OL; Fedorova, NV | 1 |
Kelemen, LE | 1 |
Guthikonda, S; Haynes, WG | 1 |
Beale, P; Clarke, SJ; Horvath, L; Ong, S; Rivory, L; Sharma, R | 1 |
Bertoletti, E; Chilovi, BV; Conti, M; Del Rio, I; Padovani, A; Rozzini, L; Trabucchi, M | 1 |
Dichgans, M; Gschwendtner, A; Herzog, J; Holtmannspötter, M; Opherk, C; Peters, N; Sämann, P | 1 |
Aboyans, V; Criqui, MH; Denenberg, JO; Fronek, A; Knoke, JD; Ridker, PM | 1 |
Chernikova, IV; Kostiuchenko, GI; Kostiuchenko, LA; Kulikov, VP | 1 |
Taute, BM | 1 |
Böger, CA; Christ, J; Götz, AK; Haak, T; Hoffmann, U; Krämer, BK; Riegger, GA; Stubanus, M | 1 |
Hasegawa, Y; Jiang, Y; Qin, J; Song, J; Sun, F; Wu, X; Yamaguchi, S; Yang, Y; Zhang, Y | 1 |
Leonova, SF; Shirokov, EA | 1 |
Archetti, S; Borroni, B; Cesana, BM; Ferrari, M; Padovani, A | 1 |
Beck, J; Hinderliter, A; Offenbacher, S; Ohman, EM; Oppenheimer, SM; Sen, PK; Sen, S; Simmons, J | 1 |
Degtereva, OA; Menshutina, MA; Panina, IIu; Petrishchev, NN; Rumiantsev, ASh; Smirnov, AV; Tugusheva, FA | 1 |
Bitetto, D; Cussigh, A; De Feo, T; Fabris, C; Falleti, E; Fontanini, E; Fornasiere, E; Marangoni, F; Minisini, R; Pirisi, M; Toniutto, P | 1 |
Crow, MK; Davis, A; Devereux, RB; Levine, DM; Lockshin, MD; Paget, SA; Roman, MJ; Salmon, JE; Sammaritano, L | 1 |
Aguglia, U; Battaglia, L; Condino, F; de Marco, V; Luise, F; Morabito, F; Morabito, P; Piromalli, A; Quattrone, A; Russo, C; Trapani Lombardo, V; Vinci, A | 1 |
Campolo, J; Caruso, R; Cighetti, G; De Maria, R; Frigerio, M; Oliva, F; Parodi, O; Parolini, M; Roubina, E; Vitali, E | 1 |
Cakal, E; Goksu, M; Ozkaya, M; Yuzbasioglu, MF | 1 |
Nehler, MR; Porter, JM; Taylor, LM | 1 |
Dennis, VW; Robinson, K | 1 |
Clarke, R; Jobst, KA; Refsum, H; Smith, AD; Sutton, L; Ueland, PM | 1 |
Moneta, GL; Porter, JM; Schuff, RA; Sexton, GJ; Taylor, LM | 1 |
Alaupovic, P; Attman, PO; Knight-Gibson, C; Larsson, R; Lee, DM; Mulec, H; Mullen, JK; Samuelsson, O; Weiss, L | 1 |
Clagett, GP; Jackson, MR; McIntyre, KE; Modrall, JG; Valentine, RJ | 1 |
Hackam, DG; Peterson, JC; Spence, JD | 1 |
Barnetson, L; Budge, M; Bungay, H; Clarke, R; Esiri, M; Frost, C; Joachim, C; King, E; Molyneux, A; Morris, J; Smith, AD | 1 |
Hayakawa, T; Kamiya, H; Kondo, J; Kosokabe, T; Matsui, H; Mukawa, H; Okumura, K; Sone, T; Suzuki, T; Tomida, T; Tsuboi, H | 1 |
Brzósko, S; Hryszko, T; Małyszko, J; Myśliwiec, M | 1 |
Beaudeux, JL; Bruckert, E; Foglietti, MJ; Giral, P; Jacob, N | 1 |
Debreceni, L | 1 |
Brown, AT; Delongchamp, RR; Fink, LM; Fonseca, VA; Poirier, LA; Randolph, CJ; Wise, CK | 1 |
Graf, S; Hornykewycz, S; Huber, K; Huber-Beckmann, R; Nikfardjam, M; Wojta, J; Zorn, G | 1 |
Emeis, JJ; Hovind, P; Parving, HH; Rossing, P; Stehouwer, CD; Tarnow, L; Teerlink, T | 1 |
Almadori, G; Bussu, F; Cadoni, G; Galli, J; Giardina, B; Minucci, A; Persichilli, S; Zappacosta, B | 1 |
Cohen, B; Lima, J; Oppenheimer, SM; Sen, S | 1 |
Dambinova, SA; Khounteev, GA; Skoromets, AA | 1 |
28 review(s) available for homocysteine and Disease Exacerbation
Article | Year |
---|---|
Serum levels of Homocysteine, Vitamin B12 and Folate in Patients with Multiple Sclerosis: an Updated Meta-Analysis.
Topics: Adult; Case-Control Studies; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multiple Sclerosis; Vitamin B 12 | 2020 |
Role of homocysteine in the development and progression of Parkinson's disease.
Topics: Disease Progression; Homocysteine; Humans; Parkinson Disease | 2020 |
Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
Topics: Arteriosclerosis; Disease Progression; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Tetrahydrofolates; Vascular Grafting; Vitamin B Complex | 2013 |
Elevated serum homocysteine level in the development of diabetic peripheral neuropathy.
Topics: Aged; Asian People; Biomarkers; Case-Control Studies; China; Diabetes Mellitus; Diabetic Neuropathies; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Risk Factors; White People | 2015 |
Homocysteine and Mild Cognitive Impairment: Are These the Tools for Early Intervention in the Dementia Spectrum?
Topics: Brain; Cognition; Cognitive Dysfunction; Dementia; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Vitamin B Complex | 2016 |
Homocysteine as a Pathological Biomarker for Bone Disease.
Topics: Animals; Biomarkers; Bone and Bones; Bone Remodeling; Chondrocytes; Collagen; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Matrix Metalloproteinases; Mitochondria; Osteoclasts; Osteogenesis; Osteoporosis; Oxidative Stress; Regional Blood Flow | 2017 |
[Biochemical alterations in patients with Down syndrome].
Topics: Acetylglucosaminidase; Adult; Alzheimer Disease; Antioxidants; Bilirubin; Blood Proteins; Cystathionine beta-Synthase; Disease Progression; Down Syndrome; Ferritins; Folic Acid; Homocysteine; Humans; Learning; Nootropic Agents; Quality of Life; S100 Proteins; Serum Albumin; Superoxide Dismutase; Transferrin; Vitamin B 12 | 2008 |
Plaque biology: interesting science or pharmacological treasure trove?
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Atherosclerosis; Biomarkers; Blood Coagulation; C-Reactive Protein; Cardiovascular Agents; Cytokines; Disease Progression; Hematologic Agents; Homocysteine; Humans; Hypolipidemic Agents; Inflammation; Intercellular Signaling Peptides and Proteins; Lipid Metabolism; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Protease Inhibitors; Signal Transduction | 2008 |
Cardiac biomarkers and chronic renal diseases.
Topics: Animals; Arginine; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Disease Progression; Homocysteine; Humans; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Troponin | 2008 |
Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Clinical Trials as Topic; Cognition Disorders; Disease Progression; Homocysteine; Humans; Lipid Metabolism; Peptide Fragments; tau Proteins | 2010 |
Fenofibrate, homocysteine and renal function.
Topics: Animals; Biomarkers; Creatinine; Disease Progression; Dyslipidemias; Fenofibrate; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Kidney; PPAR alpha; Renal Insufficiency; Risk Factors; Sulfhydryl Compounds | 2010 |
Motor complications, levodopa metabolism and progression of Parkinson's disease.
Topics: Animals; Arteriosclerosis; Catechol O-Methyltransferase; Disease Progression; Dopamine; Dyskinesias; Enzyme Inhibitors; Free Radicals; Homocysteine; Humans; Levodopa; Nerve Degeneration; Parkinson Disease; Synaptic Transmission | 2011 |
Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
Topics: Adult; Aged; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Disease Progression; Evidence-Based Medicine; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B Complex | 2012 |
Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
Topics: Arteriosclerosis; Disease Progression; Homocysteine; Humans; Peripheral Vascular Diseases | 2002 |
[Homocysteine and dementia].
Topics: Alzheimer Disease; Biomarkers; Cerebral Amyloid Angiopathy; Dementia; Dementia, Vascular; Disease Progression; Homocysteine; Humans; Risk Factors | 2003 |
Calcific aortic stenosis: another face of atherosclerosis?
Topics: Aortic Valve Stenosis; Calcinosis; Disease Progression; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Risk Factors | 2003 |
Elevated plasma homocysteine as risk factor for peripheral arterial disease--what is the evidence?
Topics: Arteriosclerosis; Disease Progression; Evidence-Based Medicine; Homocysteine; Humans; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Risk Factors | 2003 |
Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
Topics: Antiparkinson Agents; Arteriosclerosis; Catechol O-Methyltransferase; Dementia; Disease Progression; Disease Susceptibility; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Levodopa; Models, Biological; Multicenter Studies as Topic; Oxidative Stress; Parkinson Disease; Randomized Controlled Trials as Topic; Substantia Nigra | 2004 |
Role of hyperhomocysteinemia in aortic disease.
Topics: Aged; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Diseases; Collagen; Disease Progression; Extracellular Matrix; Female; Fibrillin-1; Fibrillins; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Marfan Syndrome; Microfilament Proteins; Middle Aged; Risk; Thrombosis; Vascular Diseases | 2004 |
Homocysteine: overview of biochemistry, molecular biology, and role in disease processes.
Topics: Animals; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Oxidation-Reduction | 2005 |
Biomarkers in chronic kidney disease: utility and issues towards better understanding.
Topics: Animals; Arginine; Biomarkers; C-Reactive Protein; Chronic Disease; Disease Progression; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Troponin T | 2005 |
The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?
Topics: Animals; Canada; Carrier Proteins; Cytosol; Dietary Supplements; Disease Progression; DNA, Neoplasm; Folate Receptor 1; Folate Receptors, GPI-Anchored; Folic Acid; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Homocysteine; Humans; Mutation; Neoplasms; Prognosis; Receptors, Cell Surface; Transcription Factors; Tumor Cells, Cultured; United States | 2006 |
Homocysteine: role and implications in atherosclerosis.
Topics: Atherosclerosis; Biomarkers; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Oxidative Stress; Risk Factors | 2006 |
Homocysteinemia as a risk factor for atherosclerosis: a review.
Topics: Arteriosclerosis; Coronary Artery Disease; Disease Progression; Homocysteine; Humans; Hypertension; Risk Factors | 1997 |
[Homocysteine--new risk factor for progression of atherosclerosis and its complications].
Topics: Arteriosclerosis; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors | 2001 |
[New non-lipidic biological markers of atherosclerosis].
Topics: Arteriosclerosis; Biomarkers; Blood Coagulation Factors; Cell Adhesion Molecules; Chemokines; Cytokines; Disease Progression; Endothelium, Vascular; Fibrinolysis; Foam Cells; Homocysteine; Humans; Inflammation; Monocytes; Reproducibility of Results; Risk Factors; Sensitivity and Specificity | 2001 |
[Homocysteine--a risk factor for atherosclerosis].
Topics: Antioxidants; Arteriosclerosis; Disease Progression; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Oxidative Stress; Risk Factors; Thrombosis; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2001 |
The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.
Topics: Biomarkers; Brain; Disease Progression; Double-Blind Method; Follow-Up Studies; Homocysteine; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Risk Factors; Stroke; Time Factors; Treatment Outcome; Vitamins | 2002 |
24 trial(s) available for homocysteine and Disease Exacerbation
Article | Year |
---|---|
Nitration-mediated deficiency of cystathionine β-synthase activity accelerates the progression of hyperhomocysteinemia.
Topics: Adult; Aged; Aged, 80 and over; Animals; Cystathionine beta-Synthase; Disease Models, Animal; Disease Progression; Female; Free Radical Scavengers; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metalloporphyrins; Middle Aged; Mutation; Nitro Compounds; Nitrosative Stress; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Rats, Wistar; Tyrosine | 2017 |
The effect of cardiovascular risk factors on the carotid intima-media thickness in an old-aged cohort with hypertension: a longitudinal evolution with 4-year follow-up of a random clinical trial.
Topics: Aged; Atherosclerosis; Blood Pressure; C-Reactive Protein; Carotid Intima-Media Thickness; Cholesterol; Disease Progression; Female; Heart Rate; Homocysteine; Humans; Hypertension; Life Style; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Pulse Wave Analysis; Risk Factors; Waist Circumference | 2019 |
Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Adult; Aged; Atherosclerosis; Coronary Artery Disease; Coronary Vessels; Dietary Supplements; Disease Progression; Dose-Response Relationship, Drug; Follow-Up Studies; Garlic; Homocysteine; Humans; Male; Middle Aged; Pericardium; Plant Extracts; Risk Factors; Thermometry; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Topics: Aged; Atrial Natriuretic Factor; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Disease Progression; Double-Blind Method; Female; France; Homocysteine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors | 2013 |
Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; China; Disease Progression; Double-Blind Method; Drug Combinations; Enalapril; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Vitamin B Complex | 2016 |
Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).
Topics: Aged; Biomarkers; Calcinosis; Canada; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Artery, Common; Disease Progression; Drug Combinations; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Atherosclerosis; Calcium; Carotid Arteries; Coronary Vessels; Dietary Supplements; Disease Progression; Double-Blind Method; Echocardiography; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Patient Compliance; Treatment Outcome; Vitamin B Complex | 2009 |
Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Norway; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2010 |
Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults.
Topics: Aged; Atherosclerosis; Carotid Artery Diseases; Carotid Artery, Common; Dietary Supplements; Disease Progression; Double-Blind Method; Elasticity; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Netherlands; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography | 2011 |
Elevated plasma homocysteine is associated with increased brain atrophy rates in older subjects with mild hypertension.
Topics: Aged; Aged, 80 and over; Anatomy, Cross-Sectional; Atrophy; Brain; Cerebral Infarction; Disease Progression; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Hypertension; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Prognosis; Regression Analysis; Riboflavin; Risk Factors | 2011 |
Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cysteine; Diet, Protein-Restricted; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; Prognosis; Pyridoxal Phosphate; Risk Factors; Vitamin B 12 | 2002 |
[Evaluation of atherosclerosis progression in patients treated repeatedly with hemodialysis].
Topics: Adult; Aged; Arteries; Arteriosclerosis; Calcium; Cholesterol, LDL; Disease Progression; Female; Fibrinogen; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; Phosphates; Renal Dialysis; Ultrasonography | 2002 |
Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis.
Topics: Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Gemfibrozil; Homocysteine; Humans; Hypolipidemic Agents; Male; Methylenetetrahydrofolate Reductase (NADPH2); Triglycerides | 2004 |
Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; DNA Methylation; Female; Gemcitabine; Genes, Tumor Suppressor; Genotype; Homocysteine; Humans; Lung Neoplasms; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Treatment Outcome | 2004 |
Absence of macrocytic anaemia in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anemia, Macrocytic; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Platelet Count; Sex Factors; Vitamin B 12 | 2004 |
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome | 2005 |
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study.
Topics: Adult; Cytomegalovirus Infections; Disease Progression; Female; Folic Acid; Heart Diseases; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Hyperplasia; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Tetrahydrofolates; Time Factors; Ultrasonography; Vascular Diseases | 2005 |
A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Diarrhea; Disease Progression; Fatigue; Female; Fluorouracil; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Neoplasm Metastasis; Predictive Value of Tests; Survival Analysis | 2006 |
What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L.
Topics: Aging; Arteriosclerosis; Carotid Artery Diseases; Disease Progression; Female; Homocysteine; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Risk Factors; Sex Characteristics; Vitamins | 2000 |
Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting.
Topics: Alleles; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Disease Progression; DNA Mutational Analysis; Female; Follow-Up Studies; Genotype; Homocysteine; Homozygote; Humans; Hyperplasia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Risk; Stents; Tunica Intima; Ultrasonography, Interventional; Vascular Patency | 2001 |
Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy.
Topics: Adult; Albuminuria; Creatinine; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Erythrocytes; Female; Homocysteine; Humans; Lymphocytes; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Reference Values; Regression Analysis; Renal Dialysis; S-Adenosylhomocysteine; S-Adenosylmethionine | 2001 |
Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.
Topics: Adult; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Male; Plasminogen Activator Inhibitor 1; Prospective Studies; Regression Analysis | 2001 |
The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.
Topics: Biomarkers; Brain; Disease Progression; Double-Blind Method; Follow-Up Studies; Homocysteine; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Risk Factors; Stroke; Time Factors; Treatment Outcome; Vitamins | 2002 |
Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients.
Topics: Anticoagulants; Aortic Diseases; Arteriosclerosis; Demography; Disease Progression; Echocardiography, Transesophageal; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Remission, Spontaneous; Risk Factors; Stroke; Treatment Outcome | 2002 |
119 other study(ies) available for homocysteine and Disease Exacerbation
Article | Year |
---|---|
Association of elevated blood homocysteine with cognitive decline in early, untreated Parkinson's disease.
Topics: Cognitive Dysfunction; Disease Progression; Homocysteine; Humans; Parkinson Disease | 2022 |
Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
Topics: Alzheimer Disease; Cognition; Cognitive Dysfunction; Disease Progression; Homocysteine; Humans; Neuropsychological Tests; Retrospective Studies | 2023 |
Serum Vitamin B12 and Methylmalonic Acid Status in Migraineurs: A Case-Control Study.
Topics: Adolescent; Adult; Anthropometry; Case-Control Studies; Cost of Illness; Disease Progression; Female; Homocysteine; Humans; Male; Methylmalonic Acid; Middle Aged; Migraine Disorders; Nutritional Status; Pain Measurement; Social Class; Vitamin B 12; Young Adult | 2019 |
Plasma Homocysteine Level Is Associated with the Expanded Disability Status Scale in Neuromyelitis Optica Spectrum Disorder.
Topics: Adult; Aquaporin 4; Autoantibodies; Blood Sedimentation; C-Reactive Protein; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Complement C3; Complement C4; Complement Hemolytic Activity Assay; Disease Progression; Female; Homocysteine; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Leukocyte Count; Male; Middle Aged; Neuromyelitis Optica; Severity of Illness Index | 2019 |
Homocysteine accelerates atherosclerosis by inhibiting scavenger receptor class B member1 via DNMT3b/SP1 pathway.
Topics: Animals; Apolipoproteins E; Atherosclerosis; CD36 Antigens; Diet; Disease Progression; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Down-Regulation; Foam Cells; HEK293 Cells; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Plaque, Atherosclerotic; Promoter Regions, Genetic; Protein Binding; Signal Transduction; Sp1 Transcription Factor; THP-1 Cells | 2020 |
Association Between Homocysteine and Vascular Calcification Incidence, Prevalence, and Progression in the MESA Cohort.
Topics: Aged; Aged, 80 and over; Biomarkers; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Prevalence; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; United States; Up-Regulation; Vascular Calcification | 2020 |
Homocysteine induces melanocytes apoptosis via PERK-eIF2α-CHOP pathway in vitiligo.
Topics: Adult; Apoptosis; Case-Control Studies; Cell Proliferation; Disease Progression; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Female; Folic Acid; Homocysteine; Humans; Male; Melanins; Melanocytes; Models, Biological; Signal Transduction; Transcription Factor CHOP; Vitiligo | 2020 |
Plasma Homocysteine in Patients with Coronary and Carotid Artery Disease: A Case Control Study.
Topics: Adult; Aged; Angiography; Atherosclerosis; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Coronary Artery Disease; Disease Progression; Endothelium, Vascular; Female; Homocysteine; Humans; Inflammation; Male; Middle Aged; Risk Assessment; Risk Factors | 2020 |
The diagnostic value of homocysteine for the occurrence and acute progression of chronic obstructive pulmonary disease.
Topics: Acute Disease; Aged; Correlation of Data; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Retrospective Studies | 2020 |
Plasma Homocysteine Is a Predictive Factor for Accelerated Renal Function Decline and Chronic Kidney Disease in a Community-Dwelling Population.
Topics: Age Factors; Aged; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Incidence; Independent Living; Kidney; Male; Middle Aged; Prognosis; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors | 2021 |
The role of phenylephrine in patients with small deep subcortical infarct and progressive weakness.
Topics: Aged; Anticoagulants; C-Reactive Protein; Cerebral Infarction; Disease Progression; Female; Hemoglobins; Homocysteine; Humans; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Phenylephrine; Pulse Wave Analysis; Regression Analysis; Retrospective Studies; Stroke; Tomography Scanners, X-Ray Computed; Vasoconstrictor Agents | 2017 |
Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognition; Disease Progression; Female; Folic Acid; Geriatric Assessment; Homocysteine; Humans; Hyperhomocysteinemia; Longitudinal Studies; Male; Mental Status and Dementia Tests; Neuropsychological Tests; Nutrition Assessment; Nutritional Status; Surveys and Questionnaires; Time Factors; Up-Regulation; Vitamin B 12 | 2017 |
Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke.
Topics: Age Factors; Body Mass Index; C-Reactive Protein; China; Coronary Disease; Diabetes Complications; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stroke | 2017 |
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Analysis of Variance; C-Reactive Protein; Case-Control Studies; Cognitive Dysfunction; Dementia; Disability Evaluation; Disease Progression; Female; Geriatric Assessment; Homocysteine; Humans; Inflammation; Italy; Male; Reference Values; Retrospective Studies | 2018 |
Plasma Levels of Homocysteine and the Occurrence and Progression of Rectal Cancer.
Topics: Adult; Biomarkers, Tumor; Carcinoembryonic Antigen; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Prognosis; Rectal Neoplasms; ROC Curve | 2018 |
Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy.
Topics: Adult; Advanced Oxidation Protein Products; Biomarkers; Case-Control Studies; Dipeptides; Disease Progression; Female; Genetic Association Studies; Glomerulonephritis, IGA; Homocysteine; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Oxidoreductases; Polycystic Kidney, Autosomal Dominant; Polymorphism, Single Nucleotide; Prognosis; Risk; Superoxide Dismutase | 2018 |
Low Plasma Hydrogen Sulfide Is Associated with Impaired Renal Function and Cardiac Dysfunction.
Topics: Adult; Aged; Biomarkers; Disease Progression; Echocardiography; Female; Glomerular Filtration Rate; Heart Diseases; Homocysteine; Humans; Hydrogen Sulfide; Kidney; Male; Middle Aged; Renal Insufficiency, Chronic | 2018 |
Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis.
Topics: Adult; Disability Evaluation; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Multiple Sclerosis; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2018 |
IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study.
Topics: Aged; Aged, 80 and over; Biomarkers; CD40 Ligand; Cerebral Small Vessel Diseases; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Factor 4; Prospective Studies | 2018 |
Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Infarction; Cerebrovascular Disorders; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Female; Homocysteine; Humans; Image Processing, Computer-Assisted; Independent Living; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Risk Factors | 2018 |
Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.
Topics: Adult; Disease Progression; Female; Homocysteine; Humans; Immunosuppressive Agents; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Peru; Risk Factors; Severity of Illness Index; Social Class | 2019 |
Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.
Topics: Animals; Behavior, Animal; Brain; Brain Ischemia; Disease Models, Animal; Disease Progression; Homocysteine; Hyperhomocysteinemia; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Motor Activity; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Rotarod Performance Test; Severity of Illness Index; Signal Transduction | 2019 |
Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.
Topics: Aged; Case-Control Studies; Cognitive Dysfunction; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Linear Models; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Prognosis; Prospective Studies; Uric Acid | 2019 |
[Influence of elevated homocystein level and selected lipid parameters in kidney transplant patients on the progression of atherosclerotic changes assessed by intima-media thickness index (CCA-IMT)].
Topics: Adolescent; Adult; Apolipoproteins B; Atherosclerosis; Biomarkers; Carotid Artery, Common; Carotid Intima-Media Thickness; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Transplantation; Lipoprotein(a); Male; Middle Aged; Young Adult | 2012 |
Glutathione metabolism in cobalamin deficiency type C (cblC).
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Carrier Proteins; Case-Control Studies; Child; Child, Preschool; Cysteine; Disease Progression; Female; Glutathione; Homocysteine; Homocystinuria; Humans; Infant; Lymphocytes; Male; Oxidation-Reduction; Oxidative Stress; Oxidoreductases; Oxygen; Reactive Oxygen Species; Vitamin B 12; Vitamin B 12 Deficiency | 2014 |
Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer's dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Neuropsychological Tests; Perfusion; Risk Factors; Tomography, Emission-Computed, Single-Photon | 2013 |
Insulin resistance in patients with type 1 diabetes: relationship with metabolic and inflammatory parameters.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Croatia; Diabetes Mellitus, Type 1; Disease Progression; Female; Ferritins; Glycated Hemoglobin; Homocysteine; Humans; Insulin Resistance; Leukocyte Count; Male; Metabolic Syndrome; Middle Aged; Predictive Value of Tests; Prevalence; Risk Assessment; Risk Factors; Sensitivity and Specificity; Triglycerides; Waist Circumference | 2013 |
Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction.
Topics: Animals; Blood Pressure; Blotting, Western; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Progression; Fibrosis; Glutathione; Homocysteine; Hydrogen Peroxide; Hydrogen Sulfide; Immunoenzyme Techniques; Kidney Diseases; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oxidative Stress; Signal Transduction; Sulfides; Superoxide Dismutase; Superoxides; Transforming Growth Factor beta1; Ureteral Obstruction | 2013 |
Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective.
Topics: BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Disease Progression; DNA Methylation; Epigenesis, Genetic; Female; Homocysteine; Humans; Hyperhomocysteinemia; MCF-7 Cells; Membrane Proteins; Microtubule-Associated Proteins; Proto-Oncogene Proteins; Transcriptome; Tumor Suppressor Proteins; Vitamin B 12 | 2014 |
Homocysteine and C-reactive protein associated with progression and prognosis of intracranial branch atheromatous disease.
Topics: Aged; C-Reactive Protein; Disease Progression; Female; Homocysteine; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Patient Outcome Assessment; Plaque, Atherosclerotic; Prognosis; Retrospective Studies; Risk Factors | 2013 |
A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
Topics: Adiponectin; Adult; Age Factors; Apolipoprotein A-I; Atherosclerosis; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Cytokine TWEAK; Diabetes Complications; Diabetes Mellitus; Disease Progression; Female; Homocysteine; Humans; Leptin; Longitudinal Studies; Lupus Erythematosus, Systemic; Middle Aged; Multivariate Analysis; Odds Ratio; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tumor Necrosis Factors | 2014 |
Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study.
Topics: Age Factors; Aged; Atrophy; Brain; Cerebrovascular Disorders; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Male; Middle Aged; Nerve Fibers, Myelinated; Prospective Studies; Risk Factors; Sex Factors | 2014 |
Homocysteine is linked to macular edema in type 2 diabetes.
Topics: Adult; Aged; Biomarkers; China; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Disease Progression; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Homocysteine; Humans; Immunoassay; Incidence; Macular Edema; Male; Middle Aged; Nephelometry and Turbidimetry; Prognosis; Prospective Studies; Retina; Risk Factors; Surveys and Questionnaires | 2014 |
Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.
Topics: Adolescent; Adult; Age Factors; C-Reactive Protein; Carotid Intima-Media Thickness; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Lipids; Male; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Smoking; Young Adult | 2014 |
Homocysteine, cysteine, folate and vitamin B₁₂ status in type 2 diabetic patients with chronic kidney disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Chromatography, High Pressure Liquid; Cysteine; Diabetes Mellitus, Type 2; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Renal Insufficiency, Chronic; Vitamin B 12 | 2015 |
Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Disease Progression; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Israel; Linear Models; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Superior Sagittal Sinus; Young Adult | 2014 |
Oral exposure to the anti-pyridoxine compound 1-amino D-proline further perturbs homocysteine metabolism through the transsulfuration pathway in moderately vitamin B₆ deficient rats.
Topics: Animals; Asymptomatic Diseases; Biomarkers; Cystathionine; Cystathionine gamma-Lyase; Diet; Disease Models, Animal; Disease Progression; Flax; Homocysteine; Hyperhomocysteinemia; Liver; Male; Non-alcoholic Fatty Liver Disease; Proline; Pyridoxal Phosphate; Pyridoxine; Random Allocation; Rats, Sprague-Dawley; Seeds; Vitamin B 6; Vitamin B 6 Deficiency | 2015 |
[Hyperhomocysteinemia--a predictor of inflammatory changes in the liver].
Topics: Adult; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Prognosis; Tumor Necrosis Factor-alpha | 2014 |
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension.
Topics: Adult; Aged; Asymptomatic Diseases; Austria; C-Reactive Protein; Carotid Arteries; Carotid Intima-Media Thickness; Carotid Stenosis; Cross-Sectional Studies; Disease Progression; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Statistics as Topic | 2015 |
[Study of serum albumin and BMI as nutritional markers in hemodialysis patients].
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; C-Reactive Protein; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Kaplan-Meier Estimate; Lipids; Male; Malnutrition; Middle Aged; Nutritional Status; Protein-Energy Malnutrition; Renal Dialysis; Renal Insufficiency, Chronic; Sampling Studies; Serum Albumin | 2014 |
Effects of folic acid on dyslipidemia and serum homocysteine in a rat model of cholestasis and hepatic fibrosis.
Topics: Animals; Antioxidants; Biomarkers; Cholestasis, Intrahepatic; Cytoprotection; Disease Progression; Dyslipidemias; Folic Acid; Glutathione; Homocysteine; Lipids; Liver; Liver Cirrhosis, Experimental; Male; Rats, Wistar; Time Factors | 2015 |
Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine.
Topics: Atherosclerosis; Biomarkers; Carotid Stenosis; Disease Progression; Female; Glomerular Filtration Rate; Homocysteine; Humans; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; Risk Factors | 2016 |
Carotid artery intima-media thickness associated with prognosis of intracranial branch atheromatous disease.
Topics: Aged; C-Reactive Protein; Carotid Intima-Media Thickness; Computed Tomography Angiography; Disease Progression; Female; Homocysteine; Humans; Intracranial Arterial Diseases; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Motor Disorders; Plaque, Atherosclerotic; Prognosis; Retrospective Studies | 2017 |
Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF.
Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Biomarkers; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Disease Progression; Female; Genotype; Homocysteine; Humans; Male; Sensitivity and Specificity | 2016 |
Blood concentration of aminothiols in children with relapse of nephrotic syndrome.
Topics: Adolescent; Biomarkers; Biopsy, Needle; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cohort Studies; Cross-Sectional Studies; Cyclosporine; Dipeptides; Disease Progression; Female; Follow-Up Studies; Glutathione; Homocysteine; Humans; Immunohistochemistry; Male; Nephrotic Syndrome; Recurrence; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sulfhydryl Compounds; Treatment Outcome | 2016 |
Homocysteine as a predictive biomarker in early diagnosis of renal failure susceptibility and prognostic diagnosis for end stages renal disease.
Topics: Adult; Biomarkers; C-Reactive Protein; Calcium; Case-Control Studies; Creatinine; Disease Progression; Early Diagnosis; Egypt; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Renal Dialysis; Serum Albumin | 2016 |
Homocysteine concentration in coronary artery disease: Influence of three common single nucleotide polymorphisms.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Area Under Curve; Biomarkers; Case-Control Studies; Chi-Square Distribution; Coronary Artery Disease; Cystathionine beta-Synthase; Disease Progression; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Heterozygote; Homocysteine; Homozygote; Humans; Kaplan-Meier Estimate; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Phenotype; Polymorphism, Single Nucleotide; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Risk Factors; ROC Curve; Stroke; Time Factors | 2017 |
Serum homocysteine levels in relation to clinical progression in multiple sclerosis.
Topics: Adult; Case-Control Studies; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurodegenerative Diseases; Neurology; Risk Factors | 2008 |
The relation of plasma homocysteine to radiographic knee osteoarthritis.
Topics: Disease Progression; Epidemiologic Methods; Female; Homocysteine; Humans; Male; Middle Aged; Osteoarthritis, Knee; Predictive Value of Tests; Radiography; Weight-Bearing | 2009 |
Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.
Topics: Aged; Aging; Alzheimer Disease; Brain; Cognition Disorders; Disease Progression; Female; Homocysteine; Humans; Hypertension; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated | 2009 |
Homocysteine levels and echocardiographic findings in obstructive sleep apnea syndrome.
Topics: Adult; Aged; Disease Progression; Female; Heart Diseases; Homocysteine; Humans; Male; Middle Aged; Respiratory Function Tests; Sleep Apnea, Obstructive; Ultrasonography | 2010 |
C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome.
Topics: Adult; C-Reactive Protein; Case-Control Studies; Disease Progression; Female; Heart Rate; Homocysteine; Humans; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2010 |
[Different patterns of homocysteine in patients with peripheral arterial disease].
Topics: Analysis of Variance; C-Reactive Protein; Disease Progression; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Inflammation; Nephelometry and Turbidimetry; Peripheral Vascular Diseases; Risk Factors | 2010 |
Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci.
Topics: Animals; Cell Proliferation; Colorectal Neoplasms; Dietary Supplements; Disease Progression; Folic Acid; Homocysteine; Liver; Male; Precancerous Conditions; Rats; Rats, Sprague-Dawley | 2009 |
A prospective study on the development of Alzheimer's disease with regard to thyroid-stimulating hormone and homocysteine.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Cohort Studies; Creatinine; Disease Progression; Female; Homocysteine; Humans; Male; Neuropsychological Tests; Prospective Studies; Risk Assessment; Socioeconomic Factors; Sweden; Thyrotropin | 2009 |
Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers.
Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Creatinine; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Neopterin; Vitamin B 12 | 2010 |
Thrombophilic risk factors and peripheral arterial disease severity.
Topics: Aged; Constriction, Pathologic; Disease Progression; DNA Mutational Analysis; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Ischemia; Lupus Coagulation Inhibitor; Male; Mutation; Peripheral Arterial Disease; Polymorphism, Genetic; Prothrombin; Risk Factors; Thrombophilia | 2010 |
Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA.
Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Homocysteine; Humans; Incidence; Leukocyte Count; Lipoproteins; Male; Middle Aged; Platelet Count; Prognosis; Reference Values; Retrospective Studies; Risk Assessment; Risk Factors; United States | 2010 |
Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.
Topics: Adult; Aged; Alcoholism; Aminobutyrates; Biomarkers; Case-Control Studies; Cystathionine; Disease Progression; Female; Homocysteine; Humans; Liver; Liver Cirrhosis, Alcoholic; Liver Diseases, Alcoholic; Male; Methionine; Middle Aged; Sulfur; Young Adult | 2010 |
Therapy: Vitamin B6, B9 and B12 in diabetic nephropathy--beware.
Topics: Cardiovascular Diseases; Diabetic Nephropathies; Disease Progression; Down-Regulation; Folic Acid; Homocysteine; Humans; Randomized Controlled Trials as Topic; Vitamin B 12; Vitamin B 6; Vitamins | 2010 |
Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
Topics: Aged; Biomarkers, Tumor; Disease Progression; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Vitamin B 12 | 2010 |
Recessive spastic paraparesis associated with complex I deficiency due to MTHFR mutations.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Disease Progression; Electron Transport Complex I; Genes, Recessive; Homocysteine; Homozygote; Humans; Mutation, Missense; Paraparesis, Spastic; Siblings; Young Adult | 2012 |
Inhibition of hepatic glycogen synthesis by hyperhomocysteinemia mediated by TRB3.
Topics: Animals; Cell Cycle Proteins; Disease Progression; Glycogen; Homocysteine; Humans; Hyperhomocysteinemia; Indoles; Insulin Resistance; Liver Glycogen; Methionine; Mice; Phosphorylation; PPAR gamma; Protein Serine-Threonine Kinases; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering | 2011 |
Relationship between plasma homocysteine levels and congestive heart failure in patients with acute myocardial infarction. Homocysteine and congestive heart failure.
Topics: Biomarkers; Chromatography, High Pressure Liquid; Disease Progression; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Homocysteine; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Prognosis; Proportional Hazards Models; Retrospective Studies | 2011 |
Antiphospholipid antibodies and atherosclerosis: insights from rheumatoid arthritis--a five-year follow-up study.
Topics: Adult; Antibodies, Antiphospholipid; Apolipoproteins; Arthritis, Rheumatoid; Atherosclerosis; beta 2-Glycoprotein I; Carotid Intima-Media Thickness; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Immunoglobulin A; Middle Aged; Plaque, Atherosclerotic; Prognosis; Risk Factors; Ultrasonography | 2011 |
Value and level of plasma homocysteine in patients with angina pectoris undergoing coronary angiographic study.
Topics: Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Coronary Occlusion; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Analysis | 2011 |
Cystatin C levels are associated with the prognosis of systolic heart failure patients.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Agents; China; Cystatin C; Disease Progression; Female; Heart Failure, Systolic; Heart Transplantation; Homocysteine; Hospitals, University; Humans; Inflammation Mediators; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Up-Regulation | 2011 |
Progression of prostate carcinogenesis and dietary methyl donors: temporal dependence.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Transformation, Neoplastic; Choline; Decitabine; Diet; Disease Progression; DNA Methylation; Folic Acid; Homocysteine; Humans; Male; Methionine; Mice; Mice, Nude; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin B 6 | 2012 |
Nɛ-homocysteinyl-lysine isopeptide is associated with progression of peripheral artery disease in patients treated with folic acid.
Topics: Aged; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metabolism; Middle Aged; Oxidative Stress; Peptides; Peripheral Arterial Disease; Proteins; Vitamin B Complex | 2012 |
[Hyperhomocysteinemia and plasma acute-phase proteins in patients with type 2 diabetes mellitus and severe course of atherosclerosis after vascular operations].
Topics: Atherosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Male; Middle Aged; Postoperative Complications; Risk Assessment; Severity of Illness Index; Statistics as Topic; Vascular Surgical Procedures | 2011 |
Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
Topics: Adiponectin; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Brachiocephalic Trunk; Cholesterol, Dietary; Diet, Atherogenic; Diet, Carbohydrate-Restricted; Diet, High-Fat; Dietary Proteins; Disease Models, Animal; Disease Progression; Female; Homocysteine; Mice; Mice, Knockout; Plaque, Atherosclerotic; Receptors, LDL; Risk Factors; Rupture, Spontaneous; Triglycerides | 2012 |
Homocysteine, progression of ventricular enlargement, and cognitive decline: the Second Manifestations of ARTerial disease-Magnetic Resonance study.
Topics: Aged; Aging; Atherosclerosis; Atrophy; Biomarkers; Cerebral Infarction; Cerebral Ventricles; Cognition Disorders; Disease Progression; Executive Function; Female; Homocysteine; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Risk Factors | 2013 |
[Correlation between plasma concentrations of homocysteine and diabetic polyneuropathy evaluated with the Semmes-Weinstein monofilament test in patients with type 2 diabetes mellitus].
Topics: Age Factors; Aged; Alcohol Drinking; Cardiovascular Diseases; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Progression; Female; Folic Acid; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Hypesthesia; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Overweight; Physical Examination; Risk Factors; Severity of Illness Index; Smoking; Vitamin B 12 | 2013 |
Methylenetetrahydrofolate reductase gene C677T polymorphism, plasma homocysteine and folate in end-stage renal disease dialysis and non-dialysis patients.
Topics: Adolescent; Adult; Age Factors; Disease Progression; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Single Nucleotide; Renal Dialysis; Risk Factors | 2002 |
The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study.
Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease Progression; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Assessment; ROC Curve | 2002 |
Serum folate and homocysteine levels in head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Disease Progression; Folic Acid; Head and Neck Neoplasms; Homocysteine; Humans; Hyperhomocysteinemia; Neopterin; Prognosis; Risk Factors | 2002 |
Plasma homocysteine level and the course of ischemic stroke.
Topics: Aged; Brain Ischemia; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Risk Factors; Stroke | 2003 |
[Homocysteine and progression of carotid atherosclerosis in patients with coronary disease].
Topics: Arteriosclerosis; Carotid Artery Diseases; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged | 2003 |
Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD.
Topics: Adult; Biomarkers; Central Nervous System Agents; Disease Progression; Drug Interactions; Female; Homocysteine; Humans; Huntingtin Protein; Huntington Disease; Hyperhomocysteinemia; Male; Metabolic Clearance Rate; Middle Aged; Mutation; Nerve Tissue Proteins; Neurologic Examination; Nuclear Proteins | 2004 |
Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Biomarkers; Brain; Cognition Disorders; Dementia; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Prospective Studies; Radiography; Risk Factors; tau Proteins | 2004 |
Homocysteine and progression of coronary artery disease.
Topics: Adult; Blood Glucose; Coronary Artery Disease; Disease Progression; Folic Acid; Homocysteine; Humans; Hypertension; Lipids; Male; Middle Aged; Myocardial Infarction; Obesity; Research Design; Risk Factors; Smoking; Vitamin B 12 | 2004 |
Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Disease Progression; Female; Homocysteine; Humans; Male; Regression Analysis; Statistics, Nonparametric; Time Factors | 2004 |
Increased plasma homocysteine concentrations accelerate cardiac allograft vasculopathy.
Topics: Coronary Disease; Disease Progression; Female; Heart Transplantation; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Time Factors | 2004 |
Plasma homocysteine and insulin in diabetic nephropathy: relationship to body mass index.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Homocysteine; Humans; Insulin; Male; Middle Aged; Prospective Studies; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index | 2004 |
Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment.
Topics: Adult; Anticoagulants; Betaine; Cognition Disorders; Confusion; Disease Progression; Drug Therapy, Combination; Folic Acid; Frontal Lobe; Homocysteine; Humans; Hyperhomocysteinemia; Leukoaraiosis; Magnetic Resonance Imaging; Male; Methylmalonic Acid; Remission Induction; Seizures; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2005 |
Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study.
Topics: Aged; Brain; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Magnetic Resonance Imaging; Male; Middle Aged; New York; Risk Factors; Social Class; Stroke; Vitamin B 12 Deficiency | 2005 |
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |
[Significance of homocysteines in the development of acute myocardial infarction].
Topics: Biomarkers; Disease Progression; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Homocysteine; Humans; Myocardial Infarction; Risk Factors; Severity of Illness Index | 2005 |
Plasma homocysteine predicts progression of atherosclerosis.
Topics: Adult; Aged; C-Reactive Protein; Calcinosis; Cohort Studies; Coronary Artery Disease; Coronary Disease; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Tomography, X-Ray Computed | 2005 |
Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
Topics: Adult; Aged; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide Synthase; Prognosis; Retrospective Studies; Risk Factors; Smoking | 2006 |
Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach.
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular System; Cohort Studies; Dialysis; Disease Progression; Enzyme Inhibitors; Follow-Up Studies; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Middle Aged; Models, Statistical; Models, Theoretical; Proportional Hazards Models; Proteinuria; Regression Analysis; Risk; Risk Factors; Time Factors; Treatment Outcome | 2005 |
Smoking, homocysteine and degree of arteriolar retinopathy.
Topics: Adult; Arterioles; China; Cross-Sectional Studies; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Male; Middle Aged; Odds Ratio; Ophthalmoscopy; Prevalence; Retinal Diseases; Retinal Vessels; Risk Factors; Sampling Studies; Severity of Illness Index; Smoking | 2005 |
Clinical course in Parkinson's disease with elevated homocysteine.
Topics: Affect; Aged; Aged, 80 and over; Biomarkers; Cognition; Cohort Studies; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Movement; Neuropsychological Tests; Parkinson Disease; Risk Factors; Vitamin B Complex; Vitamins | 2006 |
[Study of serum levels of homocystein, lipids and their peroxidation products in patients with coronary heart disease].
Topics: Adult; Biomarkers; Disease Progression; Female; Homocysteine; Humans; Lipid Peroxidation; Lipids; Male; Middle Aged; Myocardial Ischemia; Prognosis; Risk Factors; Severity of Illness Index | 2005 |
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cognition Disorders; Dementia; Disease Progression; Educational Status; Female; Homocysteine; Humans; Male; Memory Disorders; Neuropsychological Tests; Prognosis; Psychiatric Status Rating Scales; Risk Factors | 2006 |
Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease.
Topics: Adult; Atrophy; Brain; CADASIL; Cognition Disorders; Comorbidity; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Risk Factors; Smoking | 2006 |
Risk factors for progression of peripheral arterial disease in large and small vessels.
Topics: Aged; Ankle; Brachial Artery; C-Reactive Protein; Cholesterol, HDL; Diabetes Mellitus; Diabetic Angiopathies; Disease Progression; Female; Homocysteine; Humans; Inflammation; Lipoprotein(a); Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Predictive Value of Tests; Regression Analysis; Risk Factors; Serum Amyloid A Protein; Smoking; Toes | 2006 |
[Peculiarities of atherosclerotic injury of carotid arteries in patients with coronary artery disease with hyperhomocysteinemia].
Topics: Adult; Aged; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Coronary Disease; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Severity of Illness Index; Ultrasonography | 2006 |
[Markers predicting progression of disease in PAD: Which of them are both relevant to clinical practice and economically justifiable?].
Topics: Arterial Occlusive Diseases; Biomarkers; Cardiovascular Diseases; Cost of Illness; Disease Progression; Germany; Homocysteine; Humans; Multivariate Analysis; Peripheral Vascular Diseases; Risk Factors | 2006 |
Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Supplements; Disease Progression; Female; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Polymorphism, Single Nucleotide; Time Factors | 2007 |
Clinical and biochemical studies on Chinese patients with methylmalonic aciduria.
Topics: Adolescent; Adult; Age of Onset; Amino Acid Metabolism, Inborn Errors; Biomarkers; Child; Child, Preschool; China; Chronic Disease; Comorbidity; Disease Progression; Female; Homocysteine; Homocystinuria; Humans; Infant; Infant, Newborn; Male; Methylmalonic Acid; Methylmalonyl-CoA Mutase; Predictive Value of Tests; Prognosis; Survival Rate | 2006 |
[Neurological syndromes associated with homocystein dismetabolism].
Topics: Demyelinating Diseases; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Leukoencephalitis, Acute Hemorrhagic; Magnetic Resonance Imaging; Male; Middle Aged; Polyneuropathies; Prognosis; Risk Factors; Stroke | 2006 |
Relationship of vascular risk to the progression of Alzheimer disease.
Topics: Alzheimer Disease; Apolipoproteins E; Cerebral Arteries; Cerebrovascular Disorders; Cholesterol; Disease Progression; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperlipidemias; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors | 2007 |
Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack.
Topics: Aged; Aorta, Thoracic; Atherosclerosis; Disease Progression; Disease-Free Survival; Echocardiography, Transesophageal; Female; Follow-Up Studies; Homocysteine; Humans; Hypertension; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Prevalence; Recurrence; Risk Factors; Stroke | 2007 |
[Glomerular filtration rate is an indicator of endothelial function at early stages of chronic kidney disease].
Topics: Adult; Annexins; Biomarkers; Cardiovascular Diseases; Carotid Artery, Common; Disease Progression; Endothelium, Vascular; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Risk Factors; Tunica Intima; Ultrasonography, Doppler | 2007 |
Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.
Topics: Adult; Age Factors; Aged; Disease Progression; Female; Hepatitis C, Chronic; Homocysteine; Humans; Liver Cirrhosis; Liver Transplantation; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Recurrence | 2008 |
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.
Topics: Adult; Atherosclerosis; Biomarkers; Carotid Artery Diseases; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Risk Factors; Ultrasonography | 2007 |
Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis.
Topics: Age of Onset; Brain; Cognition Disorders; Disability Evaluation; Disease Progression; Folic Acid; Homocysteine; Hyperhomocysteinemia; Multiple Sclerosis; Multivariate Analysis; Neuropsychological Tests; Predictive Value of Tests; Up-Regulation; Vitamin B 12 Deficiency | 2008 |
Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin.
Topics: Aged; alpha-Tocopherol; Ascorbic Acid; Biomarkers; Case-Control Studies; Chronic Disease; Cysteine; Dipeptides; Disease Progression; Female; Glutathione; Heart Failure; Homocysteine; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Myocardial Ischemia; Oxidation-Reduction; Oxidative Stress; Research Design; Sulfhydryl Compounds | 2007 |
Changes in plasma levels of homocysteine in patients with acute pancreatitis.
Topics: Acute Disease; Aged; Aged, 80 and over; Blood Urea Nitrogen; C-Reactive Protein; Case-Control Studies; Creatinine; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Leukocyte Count; Lipids; Male; Middle Aged; Pancreatitis; Time Factors | 2008 |
From microalbuminuria to hyperhomocysteinemia.
Topics: Albuminuria; Diabetic Nephropathies; Disease Progression; Homocysteine; Humans | 1998 |
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Case-Control Studies; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Memory Disorders; Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Risk Factors; Vascular Diseases; Vitamin B 12 | 1998 |
Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.
Topics: Aged; Analysis of Variance; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Mortality; Multivariate Analysis; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Single-Blind Method | 1999 |
The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression.
Topics: Adult; Aged; Blood Pressure; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Prospective Studies | 1999 |
The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service.
Topics: Adult; Age Factors; Age of Onset; Amputation, Surgical; Arterial Occlusive Diseases; Blood Coagulation Disorders; Blood Pressure; Confidence Intervals; Diabetes Complications; Disease Progression; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Hypertension; Incidence; Ischemia; Lipoprotein(a); Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Peripheral Vascular Diseases; Postoperative Complications; Prevalence; Prospective Studies; Reoperation; Smoking; Treatment Outcome | 1999 |
Leukoaraiosis at presentation and disease progression during follow-up in histologically confirmed cases of dementia.
Topics: Aged; Alzheimer Disease; Blood Pressure; Brain; Dementia, Vascular; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Mental Status Schedule; Retrospective Studies; Tomography, X-Ray Computed | 2000 |
Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease.
Topics: Adult; Age of Onset; Analysis of Variance; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction | 2001 |
Serum folate and homocysteine levels in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Disease Progression; Female; Folic Acid; Head and Neck Neoplasms; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Smoking | 2002 |
Multiple panel of biomarkers for TIA/stroke evaluation.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Autoantibodies; Biomarkers; Diagnosis, Differential; Disease Progression; Female; Glutamic Acid; Glycine; Homocysteine; Humans; Hypertension; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Neuroprotective Agents; Predictive Value of Tests; Receptors, N-Methyl-D-Aspartate; Stroke; Tomography, X-Ray Computed | 2002 |